Senseonics Holdings, Inc. (SENS)
NYSEAMERICAN: SENS · Real-Time Price · USD
0.6000
-0.0250 (-4.00%)
At close: May 12, 2025, 4:00 PM
0.6118
+0.0118 (1.97%)
After-hours: May 12, 2025, 7:28 PM EDT
Senseonics Holdings Revenue
Senseonics Holdings had revenue of $6.26M in the quarter ending March 31, 2025, with 23.97% growth. This brings the company's revenue in the last twelve months to $23.68M, up 1.64% year-over-year. In the year 2024, Senseonics Holdings had annual revenue of $22.47M with 0.37% growth.
Revenue (ttm)
$23.68M
Revenue Growth
+1.64%
P/S Ratio
17.31
Revenue / Employee
$202,410
Employees
117
Market Cap
391.11M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22.47M | 82.00K | 0.37% |
Dec 31, 2023 | 22.39M | 6.00M | 36.62% |
Dec 31, 2022 | 16.39M | 2.71M | 19.85% |
Dec 31, 2021 | 13.68M | 8.73M | 176.32% |
Dec 31, 2020 | 4.95M | -16.35M | -76.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
SENS News
- 3 days ago - Senseonics Holdings, Inc. (SENS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time - GlobeNewsWire
- 13 days ago - Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM) - GlobeNewsWire
- 2 months ago - Senseonics Holdings, Inc. (SENS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care - GlobeNewsWire
- 3 months ago - Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - Senseonics Completes CE Mark Submission for Eversense 365, World's Longest-lasting Continuous Glucose Monitor - GlobeNewsWire